Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additional platelet inhibition in acute coronary syndrome patients with high platelet reactivity undergoing PCI
2010-020219-35Phase 4Terminated
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel and clopidogrel in acute coronary syndrome (ACS) (3 arms), sponsored by Royal Brompton and Harefield hospitals. Started Mar 2011; status: terminated.
02
Drugs
prasugrelclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2010-020219-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020219-35.